Week 11 - Antifungal Drugs Flashcards

1
Q

What types of fungal infections/Mycoses are there?

A
  • superficial (e.g. Scalp, mucous membranes)

- systemic (internal organs - kidneys, lung and brain, fatal in severely immunocompromised patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are fungal pathogens and what category of pathogens do they belong too?

A

Eukaryotes

  • commensal
  • environmental

-category of opportunistic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the most common opportunistic fungal pathogens?

A
  • Candida albicans (commensal)
  • aspergillus fumigatus (environmental)
  • cryptococcus neoformans (environmental)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What puts patients at a higher risk of developing fungal infections?

A

Impaired immune system
-HIV, organ transplantation, a course of long term broad-spectrum abx, premature birth, cancer, hospitalisation in ICU

Menstrual cycle in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do anti-fungal drugs target?

A

Fungal-specific processes/structures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are fungal cells structured?

A

Fungal cells have:

  • cell wall
  • plasma membrane
  • nucleus -DNA and RNA synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between fungal and human cells?

A

They have a cell wall

  • crucial for survival of the cell
  • complex structure and composition
  • no equivalent organelle in human cells

-ideal target for antifungals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does a fungal cell wall have and what is it made up of?

A
  • skeletal components
  • matrix components

-glucan (55-60%) of the cell wall
(two types of polymers of D-glucose - B1,6 glucan and B1,3 glucan)

  • mannan (35-50%) - glycosylated proteins (mannoproteins)
  • chitin (2% of the cell wall)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name some echinocandins and what their mechanism of action is

A
  • caspofungin, micafungin
    1. inhibit the enzyme B1,3 glucan synthetase
    2. Block synthesis of B1,3 glucan
    3. Fungicidal effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the target of most of the currently used antifungals?

A

The plasma membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between plasma membranes in human and fungal cells?

A

Human PM’s - contain cholesterol
Fungal PM’s - ERGOSTEROL

  • ergosterol = an essential component of fungal plasma membranes
  • in the absence of functional ergosterol biosynthesis - fungal cells cannot grow and survive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of action of antifungals that target ergosterol?

A

Either

-bind to resident ergosterol in the plasma membrane

OR

-inhibit different ergosterol biosynthetic enzymes and block de novo biosynthesis of ergosterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the types of drugs that target ergosterol?

A
  • polyene antifungals
  • azoles
  • allylamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mechanism of action of polyene antifungals?

A

-fungicidal

  • bind to ergosterol
  • and form pores in the plasma membrane which disrupt membrane integrity causing leakage of cell constituents

-higher affinity for ergosterol than cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What side effects of polyene antifungals are associated with prolonged application?

A

-severe side effects - kidney failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name some polyene antifungals, what they are used for and side effects if any

A
Amphotericin B
(Prolonged use has severe side effects)

Nystatin
(Used in treatment of oral and GI fungal infections)

-both natural in origin

17
Q

What reduces the risk of side effects after prolonged use of Amphotericin B

A

Prolonged use has severe side effects BUT

Amp B lipid complex (ABLC)

and

liposomal Amp B (L-Amp B) formulations reduce the risks

18
Q

What is a key step in ergosterol biosynthesis?

A

Lanosterol demethylation

19
Q

What is the mechanism of action of azoles?

A
  • ergosterol biosynthesis inhibitors
  • inhibit the enzyme Lanosterol C-14 demethylase

(Blocks ergosterol biosynthesis, leads to accumulation of toxic intermediates, causes growth arrest)

20
Q

What are the two types of azole antifungals?

A

Imidazoles

Triazoles

21
Q

Name some imidazoles

A

Miconazole

Clotrimazole (canesten)

Ketoconazole

22
Q

Name some examples of Triazoles

A

Fluconazole

Voriconazole

Itraconazole

23
Q

What type of antifungals are the azoles (imidazoles and Triazoles)?

A

Fungistatic

-inhibit the enzyme Lanosterol C14-demethylase

24
Q

Why are Triazoles more potent antifungals than imidazoles?

A

They have a higher affinity for the enzyme Lanosterol C14-demethylase

Hence more potent

25
Q

What is the mechanism of action of allylamines?

A

Inhibits ergosterol biosynthesis

Inhibit an earlier step before the step azoles inhibit

26
Q

Name some allylamines

A

Terbinafine

Amorolfine

27
Q

Which drug inhibits fungal DNA and RNA synthesis?

A

Flucytosine

28
Q

What is Flucytosine’s mechanism of action?

A

-inhibits fungal DNA + RNA synthesis

  1. Taken up by fungal cells
  2. Metabolised by fungal cells to 5-fluoroacil (5-FU)
  3. 5-FU is a toxic antimetabolite
  4. 5-FU inhibits DNA and RNA synthesis

-associated with high levels of resistance

29
Q

What is Flucytosine usually used in combination with?

A

Azoles

30
Q

What are fungal diseases also known as?

A

Mycoses